Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• Translocations involving the immunoglobulin heavy chain (IGH) locus are frequent in B-lymphoblastic leukemia/lymphoma (B-ALL) and multiple myeloma.
• These rearrangements can lead to oncogene upregulation by juxtaposing IGH enhancers near genes like MYC and CRLF2.

Purpose of the Study:

• To identify and characterize novel translocations involving the P2RY8 gene and the IGH locus in B-ALL.
• To investigate the expression levels of P2RY8 in patients with these novel translocations and their potential clinical implications.

Main Methods:

• Transcriptome sequencing was employed to identify recurrent translocations in B-ALL patients.
• Analysis of gene expression levels was performed to compare patients with novel translocations to healthy donors.

Main Results:

• Recurrent, novel P2RY8/IGH translocations were identified in three B-ALL patients.
• Noncoding exon 1 of P2RY8 was found to translocate to various sites within the IGH gene, forming P2RY8/IGHM, P2RY8/IGHV, and P2RY8/IGHD transcripts.
• Significantly higher expression of truncated P2RY8 was observed in affected patients compared to healthy controls.

Conclusions:

• The study describes novel P2RY8/IGH translocations in B-ALL, characterized by high P2RY8 expression.
• These findings may contribute to improved clinical diagnosis and treatment strategies for B-ALL.
• The elevated P2RY8 expression might be associated with a more aggressive clinical course and inferior patient outcomes.